Alzheimer's Disease Neuroimaging Initiative 4

Key facts

Sponsor

University of Southern California

Principal Investigator

Michael Weiner, MD, M.D

University of California, San Francisco

Intervention

Neuraceq(radiation)

Enrollment

1500 enrolled

Eligibility

55-90 years · All sexes

Timeline

2023 – 2027

Study locations (30)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Banner Alzheimer's Institute, Phoenix, Arizona, United States
• Barrow Neurological Institute, Phoenix, Arizona, United States
• Banner Sun Health Research Institute, Sun City, Arizona, United States
• University of California, Irvine, Irvine, California, United States
• University of California, San Diego, La Jolla, California, United States
• University of California, Los Angeles, Los Angeles, California, United States
• University of Southern California, Los Angeles, California, United States
• Stanford University, Palo Alto, California, United States
• University of California, San Francisco, San Francisco, California, United States
• University of California, Davis, Walnut Creek, California, United States
• Yale University, New Haven, Connecticut, United States
• Georgetown University, Washington D.C., District of Columbia, United States
• Howard University, Washington D.C., District of Columbia, United States
• Mayo Clinic, Jacksonville, Jacksonville, Florida, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

Northern California Institute of Research and Education · National Institute on Aging (NIA) · Alzheimer's Therapeutic Research Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07239843
  Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• RECRUITINGNCT06856850
  Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
• RECRUITINGNCT06803784
  Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
  Neuromed IRCCS
• ENROLLING BY INVITATIONNCT07234851
  Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• ACTIVE NOT RECRUITINGNANCT06768996
  Music, Social Attention, and Dementia
  University of California, San Francisco
• RECRUITINGNANCT06668610
  A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
  University of Campania Luigi Vanvitelli
• RECRUITINGEARLY PHASE1NCT06511752
  Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
  University of Texas at Austin
• RECRUITINGNCT06528964
  Proteinopathies Expression in Skin of Neurodegenerative Disorders
  Universidad Autonoma de San Luis Potosí

See all trials for Frontotemporal dementia →